Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method. (4th June 2015)

• Record Type: Journal Article
• Authors: Fukubayashi, Kotaro; Tanaka, Motohiko; Izumi, Kazuhiro; Watanabe, Takehisa; Fujie, Satomi; Kawasaki, Takeshi; Yoshimaru, Yoko; Tateyama, Masakuni; Setoyama, Hiroko; Naoe, Hideaki; Kikuchi, Ken; Sasaki, Yutaka
• Is Part Of: Cancer medicine. Volume 4:Number 8(2015:Aug.)
• Page Start: 1214
• Page End: 1223
• Publication Date: 2015-06-04
• Subjects: 616.994005
• DOI: 10.1002/cam4.476
• Languages: English
• ISSNs: 2045-7634

Abstract

<abstract abstract-type="graphical" xml:lang="en" id="cam4476-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Matched comparative cohort study of advanced hepatocellular carcinoma in the patients treated with sorafenib and hepatic arterial infusion chemotherapy (HAIC) suggested that the efficacy of HAIC is similar to sorafenib for survival and disease progression. In addition, HAIC might be advantageous for patients with portal vein invasion and/or without extrahepatic spread. <boxed-text content-type="graphic" id="cam4476-blkfxd-0001" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgj2cqnqs7k" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>